
Keywords: ADC; apparent diffusion coefficient; DWI; diffusion, weighted imaging; GLCM; grey level co-occurrence matrix; MRI; magnetic resonance imaging; PSA; prostate specific antigen; ROI; region of interest; Prostate cancer bone metastases; Apparent diffusion coe